Abstract
In 2018, three calcitonin gene-related peptide (CGRP) pathway monoclonal antibodies, erenumab, fremanezumab and galcanezumab, were approved in various......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
